Halogenated analogues of tamoxifen: Synthesis, receptor assay, and inhibition of MCF7 cells
β Scribed by David J. Yang; Timothy Tewson; Wayne Tansey; Li-Ren Kuang; Gregg Reger; Abdallah Cherif; Kenneth C. Wright; R. Gene Moult; Roy S. Tilbury; Kevin Chu; E. Edmund Kim; Sidney Wallace
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 425 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Chemopreventive approaches for the treatment of breast cancer have been validated clinically and with in vitro studies. The combined action of tamoxifen/allβtrans retinoic acid was advantageous in MCFβ7 cells, reducing cell proliferation, Bclβ2 and cβMyc protein levels and increasing Eβ
## Abstract The efficacy of tamoxifen in the hormonal therapy of breast cancer is well established, but therapeutic resistance is inevitable. FTIs are a new class of anticancer drugs that are in phase III clinical evaluation. Since the mechanisms of action of these 2 classes of drugs are different,
## Abstract Insulin receptor substrate 1 (IRSβ1) is a major downstream signaling protein for insulin and insulinβlike growth factor I (IGFβI) receptors, conveying signals to PIβ3K/Akt and ERK1/2 pathways. In breast cancer, IRSβ1 overexpression has been associated with tumor development, hormoneβind